Uridine, 2-deoxy-5-iodo- (BioDeep_00000841854)

   


代谢物信息卡片


1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione

化学式: C9H11IN2O5 (353.9712706)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O
InChI: InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)

描述信息

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents

同义名列表

2 个代谢物同义名

1-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-iodopyrimidine-2,4-dione; Uridine, 2-deoxy-5-iodo-



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Sakine Shirvalilou, Samideh Khoei, Sepideh Khoee, Seied Rabi Mahdavi, Nida Jamali Raoufi, Manijeh Motevalian, Mohammad Yahya Karimi. Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier. Journal of photochemistry and photobiology. B, Biology. 2020 Apr; 205(?):111827. doi: 10.1016/j.jphotobiol.2020.111827. [PMID: 32120183]
  • Timothy Kinsella, Howard Safran, Susan Wiersma, Thomas DiPetrillo, Andrew Schumacher, Kayla Rosati, John Vatkevich, Lawrence W Anderson, Kimberly D Hill, Charles Kunos, Jerry M Collins. Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 10; 25(20):6035-6043. doi: 10.1158/1078-0432.ccr-19-0862. [PMID: 31337643]
  • Radhia El Aissi, Imen Miladi, Jean-Michel Chezal, Olivier Chavignon, Elisabeth Miot-Noirault, Emmanuel Moreau. Melanoma-targeted delivery system (part 2): Synthesis, radioiodination and biological evaluation in B16F0 bearing mice. European journal of medicinal chemistry. 2016 Sep; 120(?):304-12. doi: 10.1016/j.ejmech.2016.05.019. [PMID: 27214141]
  • Hailun Ma, Yunkun Ma, Wenbin Ma, Dhanya K Williams, Teresa A Galvin, Arifa S Khan. Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys. Journal of virology. 2011 Jul; 85(13):6579-88. doi: 10.1128/jvi.00147-11. [PMID: 21543506]
  • Marie Boyd, Annette Sorensen, Anthony G McCluskey, Robert J Mairs. Radiation quality-dependent bystander effects elicited by targeted radionuclides. The Journal of pharmacy and pharmacology. 2008 Aug; 60(8):951-8. doi: 10.1211/jpp.60.8.0002. [PMID: 18644188]
  • Leonard I Wiebe, Xiao-Hong Yang, Shradha Singh, Jim Diakur. Preparation and preliminary evaluation of novel beta-cyclodextrin/IUDR prodrug formulations. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2008 Jun; 11(2):32s-43s. doi: 10.18433/j3w88t. [PMID: 19203469]
  • Timothy J Kinsella, Michael T Kinsella, Seongwon Hong, Jerry P Johnson, Brian Burback, Patricia J Tosca. Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. Cancer chemotherapy and pharmacology. 2008 Feb; 61(2):323-34. doi: 10.1007/s00280-007-0518-4. [PMID: 17562042]
  • Yonghua Xu, Mandar R Jagtap, Tam Garland, Jun Ying, Ronald C McGarry, Marc S Mendonca, Gordon McLennan. Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro. Journal of vascular and interventional radiology : JVIR. 2007 Jan; 18(1 Pt 1):73-8. doi: 10.1016/j.jvir.2006.10.001. [PMID: 17296707]
  • Eric C Ledbetter, Ronald C Riis, Thomas J Kern, Nicholas J Haley, Scott J Schatzberg. Corneal ulceration associated with naturally occurring canine herpesvirus-1 infection in two adult dogs. Journal of the American Veterinary Medical Association. 2006 Aug; 229(3):376-84. doi: 10.2460/javma.229.3.376. [PMID: 16881829]
  • David D Gibbs, Davinder S Theti, Nadya Wood, Matthew Green, Florence Raynaud, Melanie Valenti, Martin D Forster, Fraser Mitchell, Vassilios Bavetsias, Elisa Henderson, Ann L Jackman. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer research. 2005 Dec; 65(24):11721-8. doi: 10.1158/0008-5472.can-05-2034. [PMID: 16357184]
  • Yuji Seo, Tao Yan, Jane E Schupp, Tomas Radivoyevitch, Timothy J Kinsella. Schedule-dependent drug effects of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as an in vivo radiosensitizer in U251 human glioblastoma xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Oct; 11(20):7499-507. doi: 10.1158/1078-0432.ccr-05-1138. [PMID: 16243824]
  • Sameh Moharram, Aihua Zhou, Piyush Kumar, Edward E Knaus, Leonard I Wiebe. Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2'-deoxyuridine, a nucleoside-based nitric oxide donor. Nuclear medicine and biology. 2005 Aug; 32(6):641-5. doi: 10.1016/j.nucmedbio.2005.04.011. [PMID: 16026711]
  • Diana Elish, Fiza Singh, Jeffrey M Weinberg. Therapeutic options for herpes labialis: experimental and natural therapies. Cutis. 2005 Jul; 76(1):38-40. doi: ". [PMID: 16144287]
  • Craig A Schulz, Minesh P Mehta, Benham Badie, Cornelius J McGinn, H Ian Robins, Lori Hayes, Rick Chappell, Jen Volkman, Kim Binger, Rhoda Arzoomanian, Kris Simon, Dona Alberti, Christine Feierabend, Kendra D Tutsch, Keith A Kunugi, George Wilding, Timothy J Kinsella. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study. International journal of radiation oncology, biology, physics. 2004 Jul; 59(4):1107-15. doi: 10.1016/j.ijrobp.2003.12.007. [PMID: 15234045]
  • David J Maggs, Heather E Clarke. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. American journal of veterinary research. 2004 Apr; 65(4):399-403. doi: 10.2460/ajvr.2004.65.399. [PMID: 15077679]
  • Panteha Khalili, Ebrahim Naimi, Wei Yan Sun, Edward E Knaus, Leonard I Wiebe. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine. Biopharmaceutics & drug disposition. 2003 Dec; 24(9):385-95. doi: 10.1002/bdd.375. [PMID: 14689467]
  • Panteha Khalili, Ebrahim Naimi, Wei Yan Sun, Edward E Knaus, Leonard I Wiebe. Biochemical and pharmacokinetic evaluation of a novel pyrimidine nucleoside nitric oxide donor as a potential anticancer/antiviral agent. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2003 Jul; 19(4):305-13. doi: 10.1016/s0928-0987(03)00132-5. [PMID: 12885396]
  • Ulrich Roelcke, Oliver Hausmann, Adrian Merlo, John Missimer, Ralph P Maguire, Peter Freitag, Ernst W Radü, Regin Weinreich, Otmar Gratzl, Klaus L Leenders. PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002 Nov; 43(11):1444-51. doi: NULL. [PMID: 12411546]
  • L R Iwanowicz, A E Goodwin. A new bacilliform fathead minnow rhabdovirus that produces syncytia in tissue culture. Archives of virology. 2002 May; 147(5):899-915. doi: 10.1007/s00705-001-0793-z. [PMID: 12021863]
  • Panteha Khalili, Ebrahim Naimi, Edward E Knaus, Leonard I Wiebe. Pharmacokinetics and metabolism of the novel synthetic C-nucleoside, 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine. Biopharmaceutics & drug disposition. 2002 Apr; 23(3):105-13. doi: 10.1002/bdd.301. [PMID: 12173545]
  • A Kuin, F Citarella, Y G Oussoren, A F Van der Wal, L G Dewit, F A Stewart. Increased glomerular Vwf after kidney irradiation is not due to increased biosynthesis or endothelial cell proliferation. Radiation research. 2001 Jul; 156(1):20-7. doi: 10.1667/0033-7587(2001)156[0020:igvaki]2.0.co;2. [PMID: 11418069]
  • S Vanderbyl, N MacDonald, G de Jong. A flow cytometry technique for measuring chromosome-mediated gene transfer. Cytometry. 2001 Jun; 44(2):100-5. doi: 10.1002/1097-0320(20010601)44:2<100::aid-cyto1087>3.0.co;2-q. [PMID: 11378859]
  • E Galanis, R Goldberg, J Reid, P Atherton, J Sloan, H Pitot, J Rubin, A A Adjei, P Burch, S L Safgren, T E Witzig, M M Ames, C Erlichman. Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd). Annals of oncology : official journal of the European Society for Medical Oncology. 2001 May; 12(5):701-7. doi: 10.1023/a:1011182123545. [PMID: 11432631]
  • M A Walicka, S J Adelstein, A I Kassis. Chemical modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian cells in vitro. International journal of radiation biology. 2001 May; 77(5):625-30. doi: 10.1080/09553000110034630. [PMID: 11382341]
  • G de Jong, A Telenius, S Vanderbyl, A Meitz, J Drayer. Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers. Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology. 2001; 9(6):475-85. doi: 10.1023/a:1011680529073. [PMID: 11592482]
  • T J Kinsella, J E Schupp, T W Davis, S E Berry, H S Hwang, K Warren, F Balis, J Barnett, H Sands. Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Sep; 6(9):3670-9. doi: NULL. [PMID: 10999760]
  • P Span, J Heuvel, S Romain, A Piffanelli, P M Martin, A Geurts-Moespot, F Sweep. EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols. Anticancer research. 2000 Mar; 20(2A):681-7. doi: NULL. [PMID: 10810340]
  • R G Blasberg, U Roelcke, R Weinreich, B Beattie, K von Ammon, Y Yonekawa, H Landolt, I Guenther, N E Crompton, P Vontobel, J Missimer, R P Maguire, J Koziorowski, E J Knust, R D Finn, K L Leenders. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine. Cancer research. 2000 Feb; 60(3):624-35. doi: NULL. [PMID: 10676646]
  • E N Brody, M C Willis, J D Smith, S Jayasena, D Zichi, L Gold. The use of aptamers in large arrays for molecular diagnostics. Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology. 1999 Dec; 4(4):381-8. doi: 10.1016/s1084-8592(99)80014-9. [PMID: 10671648]
  • Z X Chen, J C Zheng, Y L Jiang. A new iridovirus isolated from soft-shelled turtle. Virus research. 1999 Sep; 63(1-2):147-51. doi: 10.1016/s0168-1702(99)00069-6. [PMID: 10509727]
  • F Yu, D Driss-Ecole, J Rembur, V Legue, G Perbal. Effect of microgravity on the cell cycle in the lentil root. Physiologia plantarum. 1999 Jan; 105(1):171-8. doi: 10.1034/j.1399-3054.1999.105125.x. [PMID: 11542436]
  • M S Reza, T L Whateley. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain. Journal of microencapsulation. 1998 Nov; 15(6):789-801. doi: 10.3109/02652049809008261. [PMID: 9818956]
  • M I Kaplan, W F Morgan. The nucleus is the target for radiation-induced chromosomal instability. Radiation research. 1998 Oct; 150(4):382-90. doi: 10.2307/3579656. [PMID: 9768851]
  • B M Svedenstål, K J Johanson. 5-Iododeoxyuridine-125I incorporation in vivo after exposure to a 50 Hz magnetic field. In vivo (Athens, Greece). 1998 Sep; 12(5):531-4. doi: NULL. [PMID: 9827362]
  • R J Morgan, E M Newman, J H Doroshow, K McGonigle, K Margolin, J Raschko, W Chow, G Somlo, L Leong, M Tetef, S Shibata, V Hamasaki, M Carroll, S Vasilev, S Akman, P Coluzzi, L Wagman, J Longmate, B Paz, Y Yen, R Klevecz. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. Cancer research. 1998 Jul; 58(13):2793-800. doi: NULL. [PMID: 9661893]
  • T J Kinsella, K A Kunugi, K A Vielhuber, D M Potter, M E Fitzsimmons, J M Collins. Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Jan; 4(1):99-109. doi: NULL. [PMID: 9516958]
  • C J McGinn, K A Kunugi, K D Tutsch, C Feierabend, D Alberti, M J Lindstrom, G Wilding, R Z Arzoomanian, T J Kinsella. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study. Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Aug; 2(8):1299-305. doi: . [PMID: 9816300]
  • M K Bijsterbosch, H van de Bilt, T J van Berkel. Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles. Biochemical pharmacology. 1996 Jul; 52(1):113-21. doi: 10.1016/0006-2952(96)00170-0. [PMID: 8678894]
  • T J Kinsella, M C Glennon, K A Kunugi, M J Lindstrom. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Jun; 2(6):981-9. doi: NULL. [PMID: 9816259]
  • G Mariani, S Di Sacco, D Volterrani, L Di Luca, S Buralli, R Di Stefano, J Baranowska-Kortylewicz, D Bonora, F Matteucci, S Ricci, C R Bellina, A Falcone, P A Salvadori, F Mosca, S J Adelstein, A I Kassis. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1996 Apr; 37(4 Suppl):22S-25S. doi: NULL. [PMID: 8676199]
  • A I Kassis, S S Tumeh, P Y Wen, J Baranowska-Kortylewicz, A D Van den Abbeele, R E Zimmerman, P A Carvalho, B M Garada, W C DeSisto, N O Bailey, F P Castronovo, G Mariani, P M Black, S J Adelstein. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1996 Apr; 37(4 Suppl):19S-22S. doi: NULL. [PMID: 8676198]
  • P Larsson, G Roos, R Stenling, G D Wilson, B Ljungberg. Cell proliferation in renal cell carcinoma--a comparative study of cell kinetic methods. Urological research. 1996; 24(5):291-5. doi: 10.1007/bf00304779. [PMID: 8931294]
  • V Haraldsdóttir, C Haanen, E Kalsbeek-Batenburg, F Olthuis. S-phase cells of the lymphoplasmocytic compartment in hyperdiploid multiple myeloma are diploid cells. Cytometry. 1995 Oct; 21(2):203-10. doi: 10.1002/cyto.990210213. [PMID: 8582241]
  • K T Kitchin, J L Brown. Incorporation of 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine into rodent DNA as determined by neutron activation analysis. Analytical biochemistry. 1995 Aug; 229(2):180-7. doi: 10.1006/abio.1995.1400. [PMID: 7485970]
  • M K Bijsterbosch, D Schouten, T J van Berkel. Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles. Biochemistry. 1994 Nov; 33(47):14073-80. doi: 10.1021/bi00251a016. [PMID: 7947817]
  • E A Biessen, D M Beuting, H Vietsch, M K Bijsterbosch, T J Van Berkel. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine. Journal of hepatology. 1994 Nov; 21(5):806-15. doi: 10.1016/s0168-8278(94)80243-2. [PMID: 7890898]
  • J G Tjuvajev, H A Macapinlac, F Daghighian, A M Scott, J Z Ginos, R D Finn, P Kothari, R Desai, J Zhang, B Beattie. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1994 Sep; 35(9):1407-17. doi: NULL. [PMID: 8071684]
  • P Larsson, G Roos, R Stenling, B Ljungberg. Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry. Scandinavian journal of urology and nephrology. 1994 Jun; 28(2):135-40. doi: 10.3109/00365599409180489. [PMID: 7939463]
  • B Ljungberg, P Larsson, G Roos, R Stenling, G Wilson. Cell kinetics of renal cell carcinoma studied with in vivo iododeoxyuridine incorporation and flow cytometry. The Journal of urology. 1994 Jun; 151(6):1509-13. doi: 10.1016/s0022-5347(17)35288-6. [PMID: 8189558]
  • T J Kinsella, K A Kunugi, K A Vielhuber, W McCulloch, S H Liu, Y C Cheng. An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116. Cancer research. 1994 May; 54(10):2695-700. doi: NULL. [PMID: 8168099]
  • R Rodriguez, M A Ritter, J F Fowler, T J Kinsella. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. International journal of radiation oncology, biology, physics. 1994 Apr; 29(1):105-13. doi: 10.1016/0360-3016(94)90232-1. [PMID: 8175417]
  • M G Kaplitt, J G Tjuvajev, D A Leib, J Berk, K D Pettigrew, J B Posner, D W Pfaff, S D Rabkin, R G Blasberg. Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. Journal of neuro-oncology. 1994; 19(2):137-47. doi: 10.1007/bf01306455. [PMID: 7964989]
  • G Mariani, P Collecchi, L Giuliani, J Baranowska-Kortylewicz, L Di Luca, G Meucci, P Viacava, A D Van den Abbeele, P A Salvadori, S Di Sacco. Tumor targeting potential and metabolism of 5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients with breast cancer. Annals of the New York Academy of Sciences. 1993 Nov; 698(?):204-11. doi: 10.1111/j.1749-6632.1993.tb17210.x. [PMID: 8279758]
  • C A van Hooijdonk, P E van Erp, R L Freund, G J de Jongh, J Schalkwijk, P C van de Kerkhof, P D Mier. Cell kinetic characterization of the epidermal growth factor dependent BALB/MK line using flow cytometric analysis of DNA content and iododeoxyuridine incorporation. Cell proliferation. 1993 Nov; 26(6):567-76. doi: 10.1111/j.1365-2184.1993.tb00034.x. [PMID: 9116123]
  • K A Kunugi, M J Lindstrom, T J Kinsella. Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line. Radiation research. 1993 Aug; 135(2):262-8. doi: NULL. [PMID: 7690149]
  • E E Vokes, M E Dolan, S Krishnasamy, R Mick, M J Ratain, F Berezin, D Brachman, G Whitman, R L Schilsky, J Charette. 5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis. Annals of oncology : official journal of the European Society for Medical Oncology. 1993 Aug; 4(7):591-5. doi: 10.1093/oxfordjournals.annonc.a058594. [PMID: 8395874]
  • M M Gutierrez, K M Giacomini. Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney. Biochimica et biophysica acta. 1993 Jul; 1149(2):202-8. doi: 10.1016/0005-2736(93)90202-b. [PMID: 8323939]
  • G Mariani, A Cei, P Collecchi, J Baranowska-Kortylewicz, A D Van den Abbeele, L Di Luca, R Di Stefano, P Viacava, E M Ferdeghini, S Di Sacco. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1993 Jul; 34(7):1175-83. doi: NULL. [PMID: 8315499]
  • J Tjuvajev, A Muraki, J Ginos, J Berk, J Koutcher, D Ballon, B Beattie, R Finn, F Dahighian, R Blasberg. Iododeoxyuridine uptake and retention as a measure of tumor growth. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1993 Jul; 34(7):1152-62. doi: NULL. [PMID: 8315494]
  • P A Philip, L Kaklamanis, J Carmichael, K Tonkin, H Morrison, K Gatter, A L Harris. The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo. British journal of cancer. 1993 Apr; 67(4):644-9. doi: 10.1038/bjc.1993.120. [PMID: 8471420]
  • R L Schilsky, L Janisch, F Berezin, R Mick, N J Vogelzang, M J Ratain. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer. Cancer research. 1993 Mar; 53(6):1293-6. doi: NULL. [PMID: 7680282]
  • D E Smith, D E Brenner, C A Knutsen, S J Deremer, P A Terrio, N J Johnson, P L Stetson, W D Ensminger. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs. Drug metabolism and disposition: the biological fate of chemicals. 1993 Mar; 21(2):277-83. doi: NULL. [PMID: 8097697]
  • C N Chang, S L Doong, Y C Cheng. Conversion of 5-iodo-2-pyrimidinone-2'-deoxyribose to 5-iodo-deoxyuridine by aldehyde oxidase. Implication in hepatotropic drug design. Biochemical pharmacology. 1992 May; 43(10):2269-73. doi: 10.1016/0006-2952(92)90186-m. [PMID: 1599512]
  • V Uhl, T L Phillips, G Y Ross, W J Bodell, J Rasmussen. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. International journal of radiation oncology, biology, physics. 1992; 22(3):489-94. doi: 10.1016/0360-3016(92)90860-k. [PMID: 1735685]
  • N Belotto, V Reiner, F Verga, G Canobbio, F Lietti, P Magnani, C Lucarelli. Determination of 2'-deoxy-5-iodouridine and its metabolite 5-iodouracil by high-performance liquid chromatography with ultraviolet absorbance detection in human serum. Journal of chromatography. 1991 Dec; 572(1-2):327-32. doi: 10.1016/0378-4347(91)80499-3. [PMID: 1818069]
  • P L Stetson, D P Normolle, J A Knol, N J Johnson, Z M Yang, E Sakmar, D Prieskorn, P Terrio, C A Knutsen, W D Ensminger. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits. Journal of the National Cancer Institute. 1991 Nov; 83(22):1659-67. doi: 10.1093/jnci/83.22.1659. [PMID: 1836238]
  • I Saiki, S Naito, J Yoneda, I Azuma, J E Price, I J Fidler. Characterization of the invasive and metastatic phenotype in human renal cell carcinoma. Clinical & experimental metastasis. 1991 Nov; 9(6):551-66. doi: 10.1007/bf01768583. [PMID: 1752085]
  • A D Purushotham, P McCulloch, W D George. Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved. British journal of cancer. 1991 Sep; 64(3):513-7. doi: 10.1038/bjc.1991.340. [PMID: 1911192]
  • M K Ghosh, A K Mitra. Effects of 5'-ester modification on the physicochemical properties and plasma protein binding of 5-iodo-2'-deoxyuridine. Pharmaceutical research. 1991 Jun; 8(6):771-5. doi: 10.1023/a:1015862319927. [PMID: 2062808]
  • T Igawa, S Kanda, H Kanetake, Y Saitoh, A Ichihara, Y Tomita, T Nakamura. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochemical and biophysical research communications. 1991 Jan; 174(2):831-8. doi: 10.1016/0006-291x(91)91493-v. [PMID: 1704229]
  • H Futami, A M Pilaro, M E Gruys, T C Back, H A Young, R H Wiltrout. In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells. Biotherapy (Dordrecht, Netherlands). 1991; 3(3):219-32. doi: 10.1007/bf02171685. [PMID: 1906724]
  • L I Wiebe, E E Knaus, W P Gati, T Iwashina, L McQueen. Drug-induced perturbations in the in vivo distribution of oncological radiotracers--II. 5-[125I]iodo-2'-deoxyuridine influenced by nitrobenzylthioinosine-5'-phosphate (NBMPR-P) and acyclothymidine (ACT). International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes. 1990; 41(2):159-62. doi: 10.1016/0883-2889(90)90101-l. [PMID: 2158945]
  • J Baranowska-Kortylewicz, S J Adelstein, A I Kassis. 5-iodo-2'-deoxyuridine-protein conjugates: synthesis and enzymatic degradation. Selective cancer therapeutics. 1990; 6(1):1-13. doi: 10.1089/sct.1990.6.1. [PMID: 2343200]
  • S C Remick, A B Benson, J L Weese, J K Willson, G Ramirez, G W Wirtanen, D B Alberti, L M Nieting, K D Tutsch, P H Fischer. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy. Cancer research. 1989 Nov; 49(22):6437-42. doi: NULL. [PMID: 2804987]
  • H Sato, T Takimoto, S Tanaka, H Ogura, K Shiraishi, J Tanaka. Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells. Journal of virology. 1989 Aug; 63(8):3555-9. doi: 10.1128/jvi.63.8.3555-3559.1989. [PMID: 2545926]
  • M Kozuru, N Uike, N Takeichi, S Nakagawa, H Takahira, K Shibata, H Sato. The possible mode of escape of adult T-cell leukaemia cells from antibody-dependent cellular cytotoxicity. British journal of haematology. 1989 Aug; 72(4):502-6. doi: 10.1111/j.1365-2141.1989.tb04313.x. [PMID: 2624625]
  • J Grisvard, E Guille, I Sasaki, I Sissoeff, A Valenza, S Apelgot, J Coppey, A Gaudemer. Biochemical studies of human (A549) and simian (CV1) cells labeled with 64Cu, 67Cu, and 125IUdR. Biological trace element research. 1989 Jun; 20(3):207-24. doi: 10.1007/bf02917436. [PMID: 2484754]
  • P A Speth, T J Kinsella, A E Chang, R W Klecker, K Belanger, R Smith, J Rowland, J E Cupp, J M Collins. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies. International journal of radiation oncology, biology, physics. 1989 May; 16(5):1247-50. doi: 10.1016/0360-3016(89)90292-7. [PMID: 2715075]
  • D Aroonprasert, J A Fagerland, N E Kelso, S Zheng, G N Woode. Cultivation and partial characterization of bovine astrovirus. Veterinary microbiology. 1989 Feb; 19(2):113-25. doi: 10.1016/0378-1135(89)90077-1. [PMID: 2495698]
  • J G Wagner, P L Stetson, J A Knol, J C Andrews, S Walker-Andrews, C A Knutsen, N Johnson, D Prieskorn, P Terrio, Z Yang. Steady-state arterial and hepatic venous plasma concentrations of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine in animals--drugs which are subject to both splanchnic and extra-splanchnic elimination. Selective cancer therapeutics. 1989; 5(4):193-203. doi: 10.1089/sct.1989.5.193. [PMID: 2623384]
  • K Naito, K Yamada. [Serum deoxythymidine kinase in hematological malignancy]. Gan to kagaku ryoho. Cancer & chemotherapy. 1988 Dec; 15(12):3221-6. doi: NULL. [PMID: 3196040]
  • T Yoshida, T Suzutani, M Azuma. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine. The Tohoku journal of experimental medicine. 1988 Nov; 156(3):279-90. doi: 10.1620/tjem.156.279. [PMID: 2855280]
  • S Stathaki, L I Wiebe, E E Knaus, J A Rogers, D Tovell, D L Tyrrell. Liposomes for targeted delivery of radioiodinated IVdU and 3-CH3-IVdU for non-invasive detection of herpes simplex virus encephalitis in mice. Drug design and delivery. 1988 Nov; 3(3):223-34. doi: NULL. [PMID: 2855578]
  • P E Klapper, G M Cleator, J M Bruce, M Longson. Penetration of the blood-brain barrier by the antiviral drug (E)-5-(2-iodovinyl)-2'-deoxyuridine in a rat model of herpes encephalitis. Drug design and delivery. 1988 Jul; 3(1):57-67. doi: ". [PMID: 2855575]
  • P A Speth, T J Kinsella, K Belanger, R W Klecker, R Smith, J B Rowland, J M Collins. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. Cancer research. 1988 May; 48(10):2933-7. doi: . [PMID: 2965970]
  • T J Kinsella, J Collins, J Rowland, R Klecker, D Wright, D Katz, S M Steinberg, E Glastein. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 May; 6(5):871-9. doi: 10.1200/jco.1988.6.5.871. [PMID: 2835444]
  • A Ota, G L Wilson, O Spilberg, R Pruss, D LeRoith. Functional insulin-like growth factor I receptors are expressed by neural-derived continuous cell lines. Endocrinology. 1988 Jan; 122(1):145-52. doi: 10.1210/endo-122-1-145. [PMID: 2961554]
  • P E Hermans, F R Cockerill. Antiviral agents. Mayo Clinic proceedings. 1987 Dec; 62(12):1108-15. doi: 10.1016/s0025-6196(12)62505-1. [PMID: 3500376]
  • T J Kinsella, P P Dobson, J B Mitchell, A J Fornace. Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. International journal of radiation oncology, biology, physics. 1987 May; 13(5):733-9. doi: 10.1016/0360-3016(87)90292-6. [PMID: 3570896]
  • F Besnard, F Perraud, M Sensenbrenner, G Labourdette. Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neuroscience letters. 1987 Jan; 73(3):287-92. doi: 10.1016/0304-3940(87)90260-6. [PMID: 3561869]
  • L J Buchanan, A C Riches. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives. British journal of cancer. 1987 Jan; 55(1):47-51. doi: 10.1038/bjc.1987.10. [PMID: 3814475]
  • T J Kinsella, P P Dobson, J B Mitchell. Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response. International journal of radiation oncology, biology, physics. 1986 Aug; 12(8):1519-22. doi: 10.1016/0360-3016(86)90207-5. [PMID: 3759574]
  • S E Ettinghausen, S A Rosenberg. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. Cancer research. 1986 Jun; 46(6):2784-92. doi: NULL. [PMID: 3486038]
  • R Saffhill, W J Hume. The degradation of 5-iododeoxyuridine and 5-bromodeoxyuridine by serum from different sources and its consequences for the use of the compounds for incorporation into DNA. Chemico-biological interactions. 1986 Mar; 57(3):347-55. doi: 10.1016/0009-2797(86)90008-6. [PMID: 3698122]
  • J Samuel, M J Gill, T Iwashina, D R Tovell, D L Tyrrell, E E Knaus, L I Wiebe. Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs. Antimicrobial agents and chemotherapy. 1986 Feb; 29(2):320-4. doi: 10.1128/aac.29.2.320. [PMID: 3717935]
  • K N Traill, K Ratheiser, R Pfeilschifter, G Wick. Lymphocyte membrane lipid composition and mitogen responsiveness in chickens: role of membrane 'fluidity'. European journal of immunology. 1986 Jan; 16(1):75-82. doi: 10.1002/eji.1830160115. [PMID: 3948907]
  • B Bardy, L Seuna, T Hovi. Age-specific prevalence of antibodies to pyrimidine kinase enzymes of herpes simplex virus types 1 and 2, and of varicella zoster virus. Journal of medical virology. 1986 Jan; 18(1):61-7. doi: 10.1002/jmv.1890180108. [PMID: 3003247]
  • L J Buchanan, A C Riches. Proliferative responses of rat ventral prostate: effects of variations in organ culture media and methodology. The Prostate. 1986; 8(1):63-74. doi: 10.1002/pros.2990080108. [PMID: 3511464]
  • J B Long, B X Ou. An improved method for the analysis of sister-chromatid exchange in vivo. Mutation research. 1985 Dec; 144(4):243-5. doi: 10.1016/0165-7992(85)90058-2. [PMID: 3934531]